Nuvation Bio logo

Nuvation Bio

BrandNew York, New YorkWebsite

Company Overview

Nuvation Bio is a global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio’s portfolio includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-868 (BET), and NUV-1511 (DDC). Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of the world’s leading prostate cancer medicines. Nuvation Bio has offices in New York, San Francisco, and Shanghai.
Founded
2018
Headquarters
New York, New York
Employees
51-200
46.7% growth last 12mo
Marketing Team
17
8% of company
Culture / Work-Life Signal
Overall rating
4.7 / 5
Work-life balance
4.8 / 5
Culture
4.8 / 5
Diversity & inclusion
4.8 / 5
Recommend to a friend
100%
Positive business outlook
61%

Overall Headcount Trend

Overall Headcount Trend

Company growth over the last 12 months

Hiring Activity

Open Marketing Jobs Over Time

Historical trend of active job postings

Salaries

Community Salary Data

Help build salary transparency at Nuvation Bio. Share your compensation anonymously.

Contribute

Reviews

Insights

Company data and employee profile signals for Nuvation Bio are still shown here. The full Insights page has more detail.

View insights
Marketing team
17
8% of company
Median tenure
No data
Sample is not ready
Average experience
No data
Sample is not ready
Time to promotion
No data
Employee profile signal
Leader tenure
No data
Leadership profile signal
People shown
No data
Founders, marketing leaders, and hiring contacts

News

Jobs